KIF20A and hereditary clear cell renal cell carcinoma: KIF20A may be used as a molecular target for early diagnosis and precise treatment of bladder cancer and renal cell carcinoma and to provide a basis for the study of the mechanism of bladder cancer and renal carcinoma.